These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 15494915

  • 21. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
    Sternfeld T, Schmid M, Tischleder A, Mudra S, Schlamp A, Kost BP, Gruber R, Youle M, Bogner JR, Goebel FD.
    Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
    [Abstract] [Full Text] [Related]

  • 22. Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
    Martínez E, Domingo P, Ribera E, Milinkovic A, Arroyo JA, Conget I, Pérez-Cuevas JB, Casamitjana R, de Lazzari E, Bianchi L, Montserrat E, Roca M, Burgos R, Arnaiz JA, Gatell JM.
    Antivir Ther; 2003 Oct; 8(5):403-10. PubMed ID: 14640387
    [Abstract] [Full Text] [Related]

  • 23. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
    Mallon PW, Miller J, Kovacic JC, Kent-Hughes J, Norris R, Samaras K, Feneley MP, Cooper DA, Carr A.
    AIDS; 2006 Apr 24; 20(7):1003-10. PubMed ID: 16603852
    [Abstract] [Full Text] [Related]

  • 24. Platelets, a typical source of error in real-time PCR quantification of mitochondrial DNA content in human peripheral blood cells.
    Banas B, Kost BP, Goebel FD.
    Eur J Med Res; 2004 Aug 31; 9(8):371-7. PubMed ID: 15337626
    [Abstract] [Full Text] [Related]

  • 25. Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels.
    De Felipe B, Blanco A, Soriano-Sarabia N, Muñoz-Fernández MA, Genebat M, Vallejo A, Leal M.
    Infection; 2008 Jun 31; 36(3):266-70. PubMed ID: 18463785
    [Abstract] [Full Text] [Related]

  • 26. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
    Young J, Rickenbach M, Weber R, Furrer H, Bernasconi E, Hirschel B, Tarr PE, Vernazza P, Battegay M, Bucher HC.
    Antivir Ther; 2005 Jun 31; 10(1):73-81. PubMed ID: 15751765
    [Abstract] [Full Text] [Related]

  • 27. Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).
    Slama L, Lanoy E, Valantin MA, Bastard JP, Chermak A, Boutekatjirt A, William-Faltaos D, Billaud E, Molina JM, Capeau J, Costagliola D, Rozenbaum W.
    Antivir Ther; 2008 Jun 31; 13(1):67-76. PubMed ID: 18389900
    [Abstract] [Full Text] [Related]

  • 28. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
    Walker UA, Bäuerle J, Laguno M, Murillas J, Mauss S, Schmutz G, Setzer B, Miquel R, Gatell JM, Mallolas J.
    Hepatology; 2004 Feb 31; 39(2):311-7. PubMed ID: 14767983
    [Abstract] [Full Text] [Related]

  • 29. Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals.
    Miró O, López S, Martínez E, Pedrol E, Milinkovic A, Deig E, Garrabou G, Casademont J, Gatell JM, Cardellach F.
    Clin Infect Dis; 2004 Sep 01; 39(5):710-6. PubMed ID: 15356787
    [Abstract] [Full Text] [Related]

  • 30. Constant mitochondrial DNA levels in blood leukocytes of patients enrolled in a NRTI-free therapeutic trial (BIKS-2 study).
    Amellal B, Allavena C, André-Garnier E, Ferré V, Valantin MA, Delfraissy JF, Lafeuillade A, Bonmarchand M, Calvez V, Raffi F.
    J Infect; 2007 Jun 01; 54(6):603-8. PubMed ID: 17207857
    [Abstract] [Full Text] [Related]

  • 31. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.
    Guallar JP, Gallego-Escuredo JM, Domingo JC, Alegre M, Fontdevila J, Martínez E, Hammond EL, Domingo P, Giralt M, Villarroya F.
    AIDS; 2008 Mar 12; 22(5):575-84. PubMed ID: 18316998
    [Abstract] [Full Text] [Related]

  • 32. A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.
    Cavalcanti RB, Raboud J, Shen S, Kain KC, Cheung A, Walmsley S.
    J Infect Dis; 2007 Jun 15; 195(12):1754-61. PubMed ID: 17492590
    [Abstract] [Full Text] [Related]

  • 33. Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
    Chêne G, Amellal B, Pédrono G, Gourlain K, Rancinan C, Journot V, Cotte L, Palmer P, Castro ND, Calvez V, Molina JM, ALBI-ANRS 070 Study Group.
    AIDS Res Hum Retroviruses; 2007 Jan 15; 23(1):54-61. PubMed ID: 17263633
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
    van der Valk M, Casula M, Weverlingz GJ, van Kuijk K, van Eck-Smit B, Hulsebosch HJ, Nieuwkerk P, van Eeden A, Brinkman K, Lange J, de Ronde A, Reiss P.
    Antivir Ther; 2004 Jun 15; 9(3):385-93. PubMed ID: 15259901
    [Abstract] [Full Text] [Related]

  • 35. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
    Pace CS, Martin AM, Hammond EL, Mamotte CD, Nolan DA, Mallal SA.
    Antivir Ther; 2003 Aug 15; 8(4):323-31. PubMed ID: 14518702
    [Abstract] [Full Text] [Related]

  • 36. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
    Youle M, Osio M, ALCAR Study Group.
    HIV Med; 2007 May 15; 8(4):241-50. PubMed ID: 17461852
    [Abstract] [Full Text] [Related]

  • 37. Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy.
    Nasi M, Guaraldi G, Orlando G, Durante C, Pinti M, Nemes E, Nardini G, Passarino G, Cocchi M, Esposito R, Mussini C, Cossarizza A.
    Clin Infect Dis; 2008 Oct 01; 47(7):962-8. PubMed ID: 18752438
    [Abstract] [Full Text] [Related]

  • 38. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
    Giralt M, Domingo P, Guallar JP, Rodriguez de la Concepción ML, Alegre M, Domingo JC, Villarroya F.
    Antivir Ther; 2006 Oct 01; 11(6):729-40. PubMed ID: 17310817
    [Abstract] [Full Text] [Related]

  • 39. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
    Haugaard SB, Andersen O, Pedersen SB, Dela F, Richelsen B, Nielsen JO, Madsbad S, Iversen J.
    J Med Virol; 2005 Sep 01; 77(1):29-38. PubMed ID: 16032748
    [Abstract] [Full Text] [Related]

  • 40. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
    Schindler K, Rieger A, Tura A, Gmeinhardt B, Touzeau-Römer V, Haider D, Pacini G, Ludvik B.
    Horm Metab Res; 2009 Jul 01; 41(7):573-9. PubMed ID: 19322744
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.